1. Home
  2. PSTV vs MYSZ Comparison

PSTV vs MYSZ Comparison

Compare PSTV & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • MYSZ
  • Stock Information
  • Founded
  • PSTV 1996
  • MYSZ 1999
  • Country
  • PSTV United States
  • MYSZ Israel
  • Employees
  • PSTV N/A
  • MYSZ N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • PSTV Health Care
  • MYSZ Technology
  • Exchange
  • PSTV Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • PSTV 7.1M
  • MYSZ 8.2M
  • IPO Year
  • PSTV N/A
  • MYSZ N/A
  • Fundamental
  • Price
  • PSTV $1.20
  • MYSZ $1.93
  • Analyst Decision
  • PSTV Strong Buy
  • MYSZ Strong Buy
  • Analyst Count
  • PSTV 2
  • MYSZ 1
  • Target Price
  • PSTV $13.50
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • PSTV 33.2K
  • MYSZ 79.8K
  • Earning Date
  • PSTV 03-04-2025
  • MYSZ 03-31-2025
  • Dividend Yield
  • PSTV N/A
  • MYSZ N/A
  • EPS Growth
  • PSTV N/A
  • MYSZ N/A
  • EPS
  • PSTV N/A
  • MYSZ N/A
  • Revenue
  • PSTV $5,725,000.00
  • MYSZ $9,632,000.00
  • Revenue This Year
  • PSTV $32.12
  • MYSZ $35.62
  • Revenue Next Year
  • PSTV N/A
  • MYSZ $12.88
  • P/E Ratio
  • PSTV N/A
  • MYSZ N/A
  • Revenue Growth
  • PSTV 52.63
  • MYSZ 43.89
  • 52 Week Low
  • PSTV $0.93
  • MYSZ $1.05
  • 52 Week High
  • PSTV $2.67
  • MYSZ $9.40
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 48.71
  • MYSZ 45.77
  • Support Level
  • PSTV $1.18
  • MYSZ $1.67
  • Resistance Level
  • PSTV $1.30
  • MYSZ $1.86
  • Average True Range (ATR)
  • PSTV 0.09
  • MYSZ 0.16
  • MACD
  • PSTV -0.00
  • MYSZ 0.03
  • Stochastic Oscillator
  • PSTV 45.42
  • MYSZ 41.27

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Share on Social Networks: